Business

Strategic Analysis to Understand the Competitive Outlook of Global Remdesivir Market | Hunan Warrant Pharmaceutical, Hainan Haiyaoetc, etc.

Introduction

Remdesivir (GS-5734) is a nucleoside analogue prodrug. It has inhibitory effects on pathogenic animal and human coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in-vitro and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models. In India, ICMR has approved remdesivir under Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 infection. Cipla has launched remdesivir under the brand name Cipremi (remdesivir lyophilised powder for injection 100 mg).

Impact of Covid-19 pandemic on market

Along with Covid-19 infections growing worldwide, governments of all Covid-19 hit nations are suffering from a shortage of essential medical supplies in order to provide optimum care to infected patients. Multiple therapeutic institutes globally are working to come up with a reliable treatment for Covid-19. One such treatment includes the use of hydroxychloroquine, while another is the use of antiviral drugs used in the disease management of HIV. Both these treatments have huge demand from advanced antivirals and antimalarial drugs. This leads the drug manufacturers as an off label indication for these drug classes has to be worked upon. The report will account for Covid19 as a key market contributor.

Request Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4366

  1. Global Remdesivir Market, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • 10 Mm*1 Ml in Dmso
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • 5mg
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • 10mg
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • 50mg
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • 100mg
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  2. Global Remdesivir Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Drug Store
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Company Profile:

  • Gilead Sciences
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cipla Limited
  • Kelun Pharma
  • Bright Gene
  • Hunan Warrant Pharmaceutical
  • Hainan Haiyao

Contact Us:

Mr. Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701 / +91 777 504 9802
Email: sales@prophecymarketinsights.com

Back to top button